Infectious Diseases

502 soru

Soru 221Soru →

A 6161-year-old male landscape architect presents to the emergency department in coastal Connecticut during early September. His wife reports that he has had 44 days of high-grade fever, drenching sweats, profound fatigue, and progressive confusion. His medical history is significant for a splenectomy at age 2525 following blunt abdominal trauma, and essential hypertension. Vital signs show a temperature of 39.8∘C39.8^\circ\text{C} (103.6∘F103.6^\circ\text{F}), blood pressure of 88/54 mm Hg88/54 \text{ mm Hg}, heart rate of 126/min126/\text{min}, and respiratory rate of 28/min28/\text{min}. Oxygen saturation is 88%88\% on room air. Physical examination reveals marked scleral icterus and pale conjunctivae. Auscultation of the lungs reveals bibasilar crackles.

Laboratory evaluation shows the following:

TestValue
Hemoglobin6.8 g/dL6.8 \text{ g/dL}
Platelet count72,000/mm372,000/\text{mm}^3
Leukocyte count14,200/mm314,200/\text{mm}^3
Total bilirubin5.2 mg/dL5.2 \text{ mg/dL}
Direct bilirubin0.8 mg/dL0.8 \text{ mg/dL}
Lactate dehydrogenase1,350 U/L1,350 \text{ U/L}
Blood urea nitrogen48 mg/dL48 \text{ mg/dL}
Creatinine2.6 mg/dL2.6 \text{ mg/dL}

A peripheral blood smear demonstrates numerous intraerythrocytic pleomorphic ring forms and occasional tetrad structures. Quantitative analysis reveals a parasitemia level of 16%16\%.

Which of the following is the most appropriate management for this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous clindamycin, oral quinine, and red blood cell exchange

Cevap

Intravenous clindamycin, oral quinine, and red blood cell exchange
The correct management for this patient is intravenous clindamycin, oral quinine, and red blood cell exchange. This patient's presentation of a tick-borne febrile illness in the Northeastern United States, combined with a blood smear showing intraerythrocytic tetrads, confirms the diagnosis of babesiosis. Because he has a history of splenectomy, parasitemia greater than 10%, pulmonary edema, and renal failure, he meets the criteria for severe babesiosis. Severe disease necessitates immediate red blood cell exchange transfusion to rapidly reduce the parasite load and remove inflammatory cytokines and hemolytic byproducts, administered alongside targeted antimicrobial therapy.

Adım Adım Çözüm

1
Analyze the clinical presentation and epidemiologic risk factors.
A splenectomized patient in the Northeastern United States presents with fever, jaundice, acute kidney injury, and respiratory distress.
Identifying the geographic and host risk factors helps narrow the differential for acute febrile illnesses.
2
Interpret the laboratory findings and peripheral blood smear.
Labs show severe hemolytic anemia and thrombocytopenia. The blood smear reveals intraerythrocytic tetrads (Maltese cross), which are pathognomonic for Babesia microti.
The blood smear provides the definitive diagnosis, distinguishing it from malaria (which lacks tetrads) and TTP (which has schistocytes).
3
Assess the severity of the infection.
The patient has severe babesiosis, evidenced by a parasitemia level >10%, asplenia, severe anemia (Hb < 8 g/dL), pulmonary edema, and acute kidney injury.
Determining severity is critical because it dictates whether outpatient antimicrobials are sufficient or if invasive interventional management is required.
4
Select the appropriate therapeutic regimen based on disease severity.
Severe babesiosis requires immediate red blood cell exchange transfusion combined with intravenous clindamycin and oral quinine (or IV azithromycin and PO atovaquone).
RBC exchange rapidly decreases the parasite burden and removes toxic byproducts of hemolysis, which is life-saving in severe cases.

Anahtar Kavram

Severe babesiosis (indicated by parasitemia >10%, Hb <8 g/dL, pulmonary/renal compromise, or asplenia) requires red blood cell exchange transfusion in addition to targeted antimicrobial therapy.
Tahmini Süre:2m 0s
Soru 222Soru →

A 42-year-old woman is evaluated on the medical floor for ongoing management of a bloodstream infection. She was admitted three days ago with a high fever and localized erythema surrounding a peripheral intravenous catheter site. Blood cultures were drawn, the catheter was removed, and she was started on empiric intravenous vancomycin and intravenous cefepime. The patient is currently afebrile and her localized erythema has resolved. Today, the initial blood cultures are finalized, showing growth of Staphylococcus aureus. Susceptibility testing reveals the organism is resistant to penicillin but susceptible to oxacillin, cefazolin, and vancomycin. Repeat blood cultures drawn 48 hours after admission show no growth. Which of the following is the most appropriate next step in the antibiotic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue current antibiotics and initiate intravenous cefazolin

Cevap

The most appropriate step is to discontinue the broad-spectrum empiric regimen (vancomycin and cefepime) and initiate targeted therapy with intravenous cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA).
The correct action is to narrow the antibiotic spectrum to intravenous cefazolin. The patient has confirmed methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. For MSSA bloodstream infections, targeted beta-lactam therapy (such as cefazolin, nafcillin, or oxacillin) is the standard of care and is clinically superior to vancomycin, demonstrating faster bacterial clearance and lower mortality rates. Transitioning to targeted therapy also aligns with core antibiotic stewardship principles.

Adım Adım Çözüm

1
Interpret the culture and susceptibility results.
The pathogen is Staphylococcus aureus susceptible to oxacillin, confirming it is methicillin-susceptible (MSSA).
Proper identification of the organism and its resistance profile is required to transition from empiric to definitive therapy.
2
Evaluate the current empiric antibiotic regimen.
The patient is on vancomycin (covering MRSA) and cefepime (covering Pseudomonas and other gram-negatives), which is overly broad for isolated MSSA.
Prolonged use of unnecessarily broad antibiotics drives resistance and increases the risk of adverse drug events.
3
Select the optimal definitive therapy for MSSA bacteremia.
Intravenous cefazolin (or an anti-staphylococcal penicillin like nafcillin) is chosen over vancomycin.
Clinical evidence consistently demonstrates that beta-lactams are superior to vancomycin for treating MSSA bacteremia, leading to improved survival and lower clinical failure rates.

Anahtar Kavram

Definitive antibiotic management of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia requires de-escalation to an intravenous anti-staphylococcal beta-lactam (e.g., cefazolin or nafcillin), as these agents are superior to vancomycin.
Soru 223Soru →

A 62-year-old man is evaluated in the intensive care unit for antimicrobial management. He was admitted 8 days ago after a severe motor vehicle collision resulting in multiple rib fractures and a pulmonary contusion. He has required mechanical ventilation since admission. On hospital day 6, he developed a new fever, increased purulent endotracheal secretions, and a right lower lobe consolidation on chest radiography. He was empirically started on intravenous vancomycin and piperacillin-tazobactam for suspected ventilator-associated pneumonia.

Today (hospital day 8), his temperature is 37.6°C (99.7°F), blood pressure is 122/78 mmHg, and heart rate is 84/min. Endotracheal aspirate cultures obtained on day 6 now show >105>10^5 CFU/mL of *Enterobacter cloacae*. Blood cultures remain sterile. Antimicrobial susceptibility testing for the *E. cloacae* isolate is reported below:

AntibioticResult
AmpicillinResistant
CefazolinResistant
CeftriaxoneSusceptible
CefepimeSusceptible
Piperacillin-tazobactamSusceptible
MeropenemSusceptible
TobramycinSusceptible

Which of the following is the most appropriate modification to this patient's pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue piperacillin-tazobactam and vancomycin, and initiate intravenous cefepime

Cevap

The most appropriate step is to discontinue piperacillin-tazobactam and vancomycin, and initiate intravenous cefepime.
The patient has ventilator-associated pneumonia (VAP) caused by *Enterobacter cloacae*. This organism is notorious for harboring an inducible, chromosomal *AmpC* beta-lactamase gene. A critical tenet of infectious disease management is recognizing that organisms with moderate-to-high risk of AmpC production (such as *Enterobacter*, *Citrobacter freundii*, and *Klebsiella aerogenes*) should not be treated with third-generation cephalosporins (e.g., ceftriaxone) or beta-lactam/beta-lactamase inhibitor combinations (e.g., piperacillin-tazobactam) for invasive infections. Even when these drugs are reported as 'susceptible' by the microbiology laboratory, exposing the organism to them selects for derepressed mutants that hyperproduce the AmpC enzyme, rapidly destroying the antibiotic and causing clinical failure.

The drugs of choice for invasive AmpC-producing infections are cefepime and carbapenems (e.g., meropenem), as they are relatively stable against AmpC hydrolysis. To practice appropriate antimicrobial stewardship and preserve carbapenems for highly resistant organisms, cefepime is the preferred step-down agent. Additionally, vancomycin must be discontinued because the culture did not grow methicillin-resistant *Staphylococcus aureus* (MRSA).

Adım Adım Çözüm

1
Analyze the culture data and clinical scenario.
The patient has ventilator-associated pneumonia caused by Enterobacter cloacae. Blood cultures are negative, and there is no MRSA isolated.
Establishing the definitive pathogen determines the required spectrum of antimicrobial coverage.
2
Evaluate the need for continued empiric therapy.
Vancomycin can be safely discontinued.
Since respiratory cultures did not grow MRSA, continuing vancomycin violates antibiotic stewardship principles.
3
Select the appropriate definitive beta-lactam agent based on the organism's intrinsic resistance mechanisms.
Cefepime is selected over ceftriaxone or piperacillin-tazobactam.
Enterobacter cloacae possesses an inducible AmpC beta-lactamase gene. Treating invasive infections with ceftriaxone or piperacillin-tazobactam can induce enzyme production leading to clinical failure, despite apparent in vitro susceptibility.

Anahtar Kavram

Invasive infections caused by organisms with a moderate-to-high risk of inducible AmpC production (e.g., Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii) should be treated with cefepime or a carbapenem, avoiding third-generation cephalosporins and piperacillin-tazobactam even if they appear susceptible in vitro.
Soru 224Soru →

Match each clinical presentation of an immunocompromised patient with advanced HIV infection to the most appropriate initial targeted pharmacologic therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 3434-year-old man presents with new-onset floaters, photophobia, and decreased visual acuity. Fundoscopy reveals yellow-white retinal exudates with adjacent areas of hemorrhage along the vascular arcades.
A 4242-year-old woman presents with a subacute onset of severe headache, low-grade fever, and malaise. Lumbar puncture reveals elevated opening pressure, lymphocytic pleocytosis, and encapsulated yeast cells on an India ink stain.
A 2929-year-old man presents with new-onset focal seizures and right-sided hemiparesis. MRI of the brain demonstrates multiple ring-enhancing lesions with surrounding edema, predominantly located in the basal ganglia.
A 3838-year-old man presents with a 33-week history of progressive dyspnea on exertion and a dry, nonproductive cough. Chest radiograph shows diffuse, bilateral interstitial infiltrates, and arterial blood gas reveals a PaO2PaO_2 of 6565 mm Hg.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches pair the CMV retinitis presentation with valganciclovir/ganciclovir; the Cryptococcal meningitis presentation with liposomal amphotericin B and flucytosine; the Toxoplasma encephalitis presentation with sulfadiazine, pyrimethamine, and leucovorin; and the severe Pneumocystis pneumonia presentation with trimethoprim-sulfamethoxazole and corticosteroids.
Each vignette describes a classic presentation of a major HIV-associated opportunistic infection that requires a specific first-line antimicrobial regimen. CMV retinitis is treated with valganciclovir. Cryptococcal meningitis induction requires amphotericin B and flucytosine. Toxoplasmosis is treated with sulfadiazine, pyrimethamine, and leucovorin. Severe PCP requires trimethoprim-sulfamethoxazole combined with corticosteroids to mitigate fatal inflammatory lung injury.

Adım Adım Çözüm

1
Analyze the first clinical vignette regarding the retinal findings.
Identified Cytomegalovirus (CMV) retinitis based on the description of exudates and hemorrhages.
Recognizing the specific pathogen allows for matching with its targeted antiviral therapy, valganciclovir.
2
Examine the second clinical vignette focusing on the cerebrospinal fluid (CSF) analysis.
Identified Cryptococcal meningitis based on encapsulated yeast cells visualized via India ink stain.
Determines the need for aggressive induction antifungal therapy with amphotericin B and flucytosine rather than monotherapy.
3
Evaluate the third clinical vignette involving neuroimaging findings.
Identified Toxoplasma encephalitis based on multiple ring-enhancing lesions in the basal ganglia.
Guides the selection of targeted anti-parasitic therapy with sulfadiazine and pyrimethamine.
4
Assess the fourth clinical vignette noting the respiratory symptoms and blood gas results.
Identified severe Pneumocystis jirovecii pneumonia (PCP) due to the characteristic infiltrates and a PaO2PaO_2 of 6565 mm Hg.
A PaO2<70PaO_2 < 70 mm Hg is a strict indication to add systemic corticosteroids to the primary antimicrobial therapy (trimethoprim-sulfamethoxazole) to reduce mortality.

Anahtar Kavram

Diagnosis and initial targeted pharmacotherapy for major opportunistic infections in patients with advanced HIV/AIDS.
Soru 225Soru →

A 6868-year-old woman is brought to the emergency department by her family due to a 2424-hour history of severe generalized headache, high fever, and progressive confusion. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 110/70 mmHg110/70 \text{ mmHg}, pulse is 115/min115/\text{min}, and respirations are 18/min18/\text{min}. On physical examination, the patient is lethargic and oriented only to her name. She exhibits nuchal rigidity. There are no focal neurologic deficits, and funduscopic examination reveals no papilledema. Which of the following represents the most appropriate sequence of steps in the management of this patient?

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of management is: First, obtain blood cultures; second, administer empiric intravenous antibiotics and dexamethasone; third, perform a noncontrast CT scan of the head; and finally, perform a lumbar puncture.
The standard of care for suspected bacterial meningitis is typically to obtain blood cultures, perform a lumbar puncture, and then start antibiotics. However, this patient has distinct indications for a CT scan of the head prior to a lumbar puncture (specifically, age greater than 60 and altered mental status). In this scenario, blood cultures must be drawn immediately to preserve the ability to identify the pathogen. Immediately afterward, empiric antibiotics (e.g., ceftriaxone, vancomycin, ampicillin) and dexamethasone must be administered. Antibiotics should never be delayed for the CT scan or lumbar puncture, as delays drastically increase mortality. Once medical therapy is initiated, the CT scan is performed to rule out any mass effect, followed finally by the lumbar puncture if the imaging is clear.

Adım Adım Çözüm

1
Evaluate the clinical presentation and identify the suspected diagnosis.
The patient's fever, headache, nuchal rigidity, and altered mental status strongly suggest bacterial meningitis.
Recognizing the life-threatening nature of bacterial meningitis dictates the urgency of subsequent interventions.
2
Assess for indications requiring neuroimaging prior to cerebrospinal fluid analysis.
The patient's age (greater than 60) and altered mental status (lethargic, confused) mandate a CT scan before a lumbar puncture.
Performing a lumbar puncture in the presence of elevated intracranial pressure or a mass lesion can precipitate fatal cerebral herniation.
3
Determine the appropriate sequencing of diagnostic and therapeutic interventions.
Blood cultures are drawn immediately, followed by the administration of empiric antibiotics and dexamethasone, before sending the patient for a CT scan. The lumbar puncture is performed last.
Antibiotic administration must not be delayed by the need for a CT scan or lumbar puncture, as delays significantly increase mortality. However, blood cultures must be drawn before antibiotics to ensure pathogen recovery.

Anahtar Kavram

Management sequence for suspected bacterial meningitis with indications for head imaging
Soru 226Soru →

Match the following clinical exposure scenarios with their most appropriate post-exposure prophylaxis or empiric treatment regimen.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Close contact with a patient diagnosed with Neisseria meningitidis meningitis
Sustained a deep puncture wound from a domestic cat bite
Found an engorged Ixodes scapularis tick attached for >36 hours in a Lyme-endemic region
Sustained a high-risk needlestick injury from a patient with a known, untreated HIV infection

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Meningococcal contact requires Rifampin/Ciprofloxacin/Ceftriaxone; Cat bite requires Amoxicillin-clavulanate; High-risk tick bite requires single-dose Doxycycline; HIV needlestick requires Three-drug antiretroviral therapy.
Each exposure corresponds to a specific, evidence-based prophylactic or early treatment regimen designed to eradicate the most likely transmitted pathogen before an active infection becomes established.

Adım Adım Çözüm

1
Analyze each exposure scenario to identify the primary pathogen of concern.
Pathogens identified include Neisseria meningitidis, Pasteurella multocida, Borrelia burgdorferi, and HIV.
Accurate pathogen identification dictates the choice of targeted prophylaxis.
2
Select the guideline-recommended prophylactic or empiric regimen for each identified pathogen risk.
Matched the appropriate antimicrobial or antiretroviral regimen to each specific exposure.
Prophylaxis must target the specific organism's susceptibilities to effectively prevent disease development.

Anahtar Kavram

Post-exposure prophylaxis and early empiric treatment regimens for common infectious exposures.
Soru 227Soru →

Match each patient's clinical presentation and peripheral blood smear findings with the most appropriate definitive antimalarial treatment regimen.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 29-year-old journalist returning from Nigeria presents with confusion and jaundice. Vitals: T 39.8°C (103.6°F), BP 90/60 mmHg. Labs show creatinine 3.1 mg/dL. Smear reveals 11% parasitemia with crescent-shaped gametocytes and multiple rings per RBC.
A 35-year-old aid worker returning from rural Honduras presents with severe chills followed by high fevers every 48 hours. Exam reveals splenomegaly. Smear shows enlarged, pale erythrocytes with fine red stippling and amoeboid trophozoites. Normal G6PD.
A 42-year-old tourist returning from Thailand presents with fever, headache, and myalgias. Vitals are stable, and labs show normal organ function. Smear shows 1.5% parasitemia with appliqué ring forms on the erythrocyte margins.
A 50-year-old researcher returning from a chloroquine-susceptible Caribbean nation presents with fevers peaking every 72 hours. Exam is unremarkable between episodes. Smear demonstrates compact, band-like trophozoites inside normal-sized erythrocytes.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches synthesize the Plasmodium species identified via smear morphology, clinical severity, regional resistance patterns, and the presence of a hypnozoite phase to assign the definitive pharmacological regimen.
The correct pairings require precise synthesis of microbiologic findings (smear morphology), clinical status (severe vs. uncomplicated), and geographic resistance data. Severe P. falciparum requires IV artesunate. Uncomplicated CQ-resistant P. falciparum requires oral ACT. P. vivax requires CQ plus primaquine for hypnozoites. P. malariae requires only CQ.

Adım Adım Çözüm

1
Evaluate the first scenario (Nigeria).
Identified as severe P. falciparum based on >10% parasitemia, CNS symptoms, acute kidney injury, and crescent gametocytes.
Determining species and severity dictates the urgent need for intravenous artesunate therapy.
2
Evaluate the second scenario (Honduras).
Identified as P. vivax based on 48-hour fevers, enlarged RBCs, and Schüffner's dots.
P. vivax has a dormant liver stage (hypnozoites) requiring specific anti-relapse therapy with primaquine in addition to chloroquine.
3
Evaluate the third scenario (Thailand).
Identified as uncomplicated P. falciparum from a chloroquine-resistant region based on 1.5% parasitemia and appliqué rings.
Requires an oral artemisinin-based combination therapy; no primaquine is needed as there is no liver stage.
4
Evaluate the fourth scenario (Caribbean).
Identified as P. malariae based on 72-hour fever cycles and band-like trophozoites.
Indicates a chloroquine-sensitive strain with no liver stage, treated definitively with chloroquine monotherapy.

Anahtar Kavram

Diagnosis and targeted pharmacotherapy of malaria based on Plasmodium species morphology, clinical severity, geographic resistance patterns, and the presence of a hypnozoite phase.
Tahmini Süre:2m 30s
Soru 228Soru →

A 24-year-old man comes to the clinic due to a sore on his penis that he noticed 5 days ago. He reports no pain, itching, or penile discharge. He is sexually active with a new male partner and does not use condoms consistently. Vital signs are within normal limits. Physical examination reveals a single, 1.5-cm, sharply circumscribed, indurated, and painless ulcer on the penile shaft. Bilateral, non-tender inguinal lymphadenopathy is present. Which of the following is the most appropriate pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Intramuscular benzathine penicillin G

Cevap

Intramuscular benzathine penicillin G
The patient's painless, indurated genital ulcer with non-tender inguinal lymphadenopathy is the classic presentation of a primary syphilitic chancre, caused by the spirochete Treponema pallidum. The most appropriate first-line treatment for primary, secondary, and early latent syphilis is a single dose of intramuscular benzathine penicillin G.

Adım Adım Çözüm

1
Analyze the clinical presentation of the genital ulcer.
The patient has a single, indurated, sharply circumscribed, and painless ulcer accompanied by non-tender inguinal lymphadenopathy.
Identifying the specific characteristics of genital ulcers (painful vs. painless, single vs. multiple, purulent vs. clean) is essential for diagnosing the underlying sexually transmitted infection.
2
Formulate the most likely diagnosis.
The classic presentation of a painless chancre indicates primary syphilis caused by Treponema pallidum.
Other common causes of genital ulcers, such as herpes simplex virus and Haemophilus ducreyi, typically present with painful lesions.
3
Select the appropriate pharmacotherapy based on the diagnosis.
Intramuscular benzathine penicillin G is selected.
A single dose of long-acting intramuscular benzathine penicillin G is the standard of care and highly effective first-line therapy for primary, secondary, and early latent syphilis.

Anahtar Kavram

The hallmark of primary syphilis is a painless, indurated genital chancre, and the standard first-line treatment is a single dose of intramuscular benzathine penicillin G.
Tahmini Süre:45s
Soru 229Soru →

A 5858-year-old man is evaluated in the intensive care unit for worsening respiratory status. Eight days ago, he was intubated following a severe motor vehicle collision. Over the past 2424 hours, his oxygen requirements have increased, and he has developed a fever of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}). Copious thick, purulent secretions are noted in the endotracheal tube. Physical examination reveals coarse rhonchi over the right lung field. Laboratory studies show a leukocyte count of 16,500/mm316,500/\text{mm}^3 with 85%85\% neutrophils. A chest radiograph demonstrates a new dense consolidation in the right lower lobe. The patient was empirically started on intravenous vancomycin, piperacillin-tazobactam, and amikacin.

Today, the quantitative endotracheal aspirate culture returns positive for >105 CFU/mL>10^5\text{ CFU/mL} of *Pseudomonas aeruginosa*. The isolate is susceptible to piperacillin-tazobactam, cefepime, meropenem, and amikacin. Blood cultures show no growth. His serum creatinine has increased from 1.0 mg/dL1.0\text{ mg/dL} on admission to 2.3 mg/dL2.3\text{ mg/dL} today.

Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and amikacin; continue piperacillin-tazobactam

Cevap

The most appropriate next step is to discontinue vancomycin and amikacin, and continue piperacillin-tazobactam monotherapy.
The correct answer discontinues both vancomycin and amikacin while continuing piperacillin-tazobactam. This patient developed ventilator-associated pneumonia (VAP), and empiric therapy appropriately included coverage for MRSA (vancomycin) and dual coverage for Pseudomonas (piperacillin-tazobactam and amikacin). Once culture and susceptibility results are available, therapy must be de-escalated to targeted treatment. Since no MRSA was isolated, vancomycin should be stopped. For definitive therapy of P. aeruginosa VAP, once in vitro susceptibility to a beta-lactam (like piperacillin-tazobactam) is confirmed, double coverage with an aminoglycoside is no longer recommended because it does not improve outcomes and increases the risk of toxicity. Given this patient's rising creatinine (acute kidney injury), discontinuing the nephrotoxic aminoglycoside is especially critical. Therefore, monotherapy with piperacillin-tazobactam is the most appropriate definitive step.

Adım Adım Çözüm

1
Interpret the clinical presentation and culture results.
The patient has ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, which is susceptible to piperacillin-tazobactam.
Establishing the definitive microbiological diagnosis is required to tailor antimicrobial therapy.
2
Evaluate the indication for continuing methicillin-resistant Staphylococcus aureus (MRSA) coverage.
Discontinue vancomycin.
The respiratory culture did not grow MRSA, making ongoing empiric coverage unnecessary and contrary to antibiotic stewardship principles.
3
Determine the optimal antipseudomonal regimen based on susceptibilities and patient factors.
Discontinue amikacin and maintain piperacillin-tazobactam monotherapy.
Dual antipseudomonal therapy is not indicated once in vitro susceptibility to a beta-lactam is confirmed. Stopping the aminoglycoside is especially critical given the patient's acute kidney injury.

Anahtar Kavram

Definitive management of Ventilator-Associated Pneumonia (VAP) requires de-escalating from broad-spectrum empiric therapy to targeted monotherapy once pathogen susceptibilities are identified.
Soru 230Soru →

A 65-year-old man is hospitalized for community-acquired pneumonia. Upon admission, he was empirically started on intravenous ceftriaxone and azithromycin. Two days later, his clinical condition has significantly improved. He is now afebrile, his oxygen saturation is 96% on room air, and his cough has decreased. He is eating well and tolerating oral intake. Sputum culture results return positive for Streptococcus pneumoniae. Susceptibility testing shows the organism is highly sensitive to penicillin, amoxicillin, ceftriaxone, and levofloxacin. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Transition to oral amoxicillin

Cevap

Transition to oral amoxicillin
The patient has community-acquired pneumonia that has clinically improved, and he is now able to tolerate oral intake. This marks the appropriate time to transition from intravenous to oral antibiotics. Furthermore, culture results show Streptococcus pneumoniae that is highly sensitive to amoxicillin. According to principles of antibiotic stewardship, therapy should be de-escalated to the narrowest spectrum agent that is effective. Oral amoxicillin perfectly fits these criteria, minimizing the risk of adverse effects and antimicrobial resistance.

Adım Adım Çözüm

1
Evaluate the patient's clinical trajectory.
The patient is afebrile, oxygenating well on room air, and tolerating oral intake, indicating readiness to switch from intravenous to oral therapy.
Clinical stability dictates whether a patient can be safely de-escalated to oral antibiotics.
2
Analyze the culture and susceptibility data.
Sputum culture confirms Streptococcus pneumoniae that is sensitive to penicillin and amoxicillin.
Culture data allows for de-escalation from empiric broad-spectrum coverage to targeted narrow-spectrum therapy.
3
Select the most appropriate targeted therapy.
Oral amoxicillin provides the narrowest effective spectrum for this pathogen in an orally bioavailable form.
Antibiotic stewardship principles require using the narrowest spectrum, most effective, and least toxic agent available.

Anahtar Kavram

Antibiotic stewardship and de-escalation in community-acquired pneumonia
Soru 231Soru →

A 26-year-old woman presents to the clinic for sexually transmitted infection screening. She reports having condomless sexual intercourse with a new male partner three weeks ago. She recently learned that this partner is living with HIV and is not taking any medications. She currently feels well and has no symptoms of acute illness. Vital signs and physical examination are unremarkable. The physician decides to evaluate her for HIV. Assuming her initial screening test is reactive, but her subsequent confirmatory antibody test is indeterminate, arrange the following diagnostic and management steps in the correct chronological sequence according to the standard Centers for Disease Control and Prevention (CDC) HIV algorithm.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with the HIV-1/2 antigen/antibody combination immunoassay, followed by the HIV-1/HIV-2 antibody differentiation immunoassay. Due to the indeterminate result, an HIV-1 nucleic acid test (NAT) is performed next. Finally, antiretroviral therapy (ART) is initiated and baseline labs are drawn.
The correct sequence precisely follows the CDC diagnostic algorithm for HIV. The first step is the highly sensitive fourth-generation antigen/antibody combination test. If reactive, the second step is the differentiation assay to determine if the patient has HIV-1 or HIV-2 antibodies. Because this patient is in the acute phase of infection (only 3 weeks post-exposure), she has p24 antigenemia but has not yet developed a mature antibody response, resulting in a reactive step 1 but an indeterminate step 2. This specific discrepancy mandates step 3, an HIV-1 nucleic acid test (NAT), to detect viral RNA and confirm acute HIV-1 infection. Once the diagnosis is definitively confirmed by a positive NAT, step 4 is to initiate antiretroviral therapy (ART) and obtain baseline immunologic and virologic studies such as a CD4 count.

Adım Adım Çözüm

1
Perform the HIV-1/2 antigen/antibody combination immunoassay.
The test returns a reactive result.
This fourth-generation test is the highly sensitive initial screening tool mandated by the CDC algorithm, detecting both p24 antigen and antibodies.
2
Perform the HIV-1/HIV-2 antibody differentiation immunoassay.
The test returns an indeterminate result.
All reactive initial screens must be followed by this test to confirm infection and differentiate the viral type. The indeterminate result occurs because the patient is in the acute window phase (p24 antigen is present, but mature antibodies have not yet formed).
3
Perform an HIV-1 nucleic acid test (NAT).
The NAT returns a positive result for HIV-1 RNA.
NAT is required to resolve the discrepancy between the reactive combination test and the indeterminate differentiation test, confirming the diagnosis of acute HIV-1 infection.
4
Initiate antiretroviral therapy (ART) and obtain a baseline CD4 cell count.
The patient is started on a modern ART regimen.
Once the diagnosis is definitively confirmed via NAT, prompt initiation of ART is standard of care to suppress viral replication, preserve immune function, and prevent transmission.

Anahtar Kavram

Standard CDC HIV Diagnostic Algorithm and Identification of Acute HIV Infection
Soru 232Soru →

Match each patient's clinical and microbiological presentation with the most appropriate targeted antimicrobial therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

An elderly patient with meningitis whose cerebrospinal fluid culture yields motile, Gram-positive bacilli.
A hospitalized patient with pyelonephritis whose urine culture grows Escherichia coli resistant to third-generation cephalosporins.
A severely neutropenic patient with a cavitary lung lesion, hemoptysis, and positive serum galactomannan assay.
A hemodialysis patient with a catheter-site infection and blood cultures growing Gram-positive cocci in clusters resistant to oxacillin.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Listeria monocytogenes pairs with ampicillin; ESBL-producing E. coli pairs with meropenem; invasive aspergillosis pairs with voriconazole; and MRSA pairs with vancomycin.
Each pathogen has a distinct, well-established first-line treatment. Ampicillin is uniquely active against Listeria. Carbapenems (meropenem) are stable against extended-spectrum beta-lactamases produced by resistant Gram-negative rods. Voriconazole is the antifungal of choice for invasive Aspergillus. Vancomycin provides reliable coverage for oxacillin-resistant staphylococci (MRSA).

Adım Adım Çözüm

1
Identify the underlying pathogen described in each clinical vignette using key microbiological and serological terms.
Pathogens identified are Listeria monocytogenes, ESBL E. coli, Aspergillus species, and MRSA.
Accurate pathogen identification is required to select narrow, targeted antimicrobial therapy.
2
Determine the first-line targeted therapy for each identified organism.
Ampicillin for Listeria, meropenem for ESBL, voriconazole for Aspergillus, and vancomycin for MRSA.
Applying standard pharmacotherapy guidelines ensures effective treatment while adhering to antimicrobial stewardship principles.

Anahtar Kavram

Targeted Antimicrobial Therapy for Classic Pathogens
Tahmini Süre:1m 0s
Soru 233Soru →

An oncology team is evaluating a 47-year-old male inpatient who has had persistent fever despite ongoing antimicrobial therapy. He has been hospitalized for the past 1616 days receiving induction chemotherapy for acute myeloid leukemia. Six days prior to the current evaluation, his absolute neutrophil count dropped to 90/mm390/\text{mm}^3, coinciding with a new-onset fever of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}). At that time, comprehensive pan-culturing was performed, and empiric intravenous piperacillin-tazobactam was initiated.

Currently, the patient's temperature is 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure is 122/78 mmHg122/78 \text{ mmHg}, and pulse is 95/min95/\text{min}. He reports feeling exhausted but has no focal symptoms such as cough, dyspnea, sinus pain, or dysuria. Physical examination reveals a clean, non-tender central venous catheter insertion site. Cardiopulmonary and abdominal examinations are unremarkable. The absolute neutrophil count remains profoundly low at 40/mm340/\text{mm}^3. All previous blood and urine cultures have remained sterile after six days of incubation. High-resolution computed tomography of the chest demonstrates no pulmonary nodules or infiltrates.

Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Add intravenous caspofungin

Cevap

The most appropriate next step is to add an empiric antifungal agent, such as intravenous caspofungin.
Adding intravenous caspofungin is the correct next step. The patient has persistent neutropenic fever, defined as a fever lasting longer than 4 to 7 days despite receiving appropriate initial empiric broad-spectrum antibacterial therapy (in this case, piperacillin-tazobactam). In high-risk patients (such as those with profound neutropenia from induction chemotherapy), persistent fever often indicates an occult invasive fungal infection, most frequently involving Candida or Aspergillus species. Standard of care requires the addition of empiric antifungal therapy with an echinocandin (like caspofungin), a mold-active azole, or liposomal amphotericin B while continuing the antibacterial regimen until the neutrophil count recovers.

Adım Adım Çözüm

1
Identify the patient's primary clinical syndrome.
The patient has high-risk, prolonged neutropenic fever (ANC <500/mm3< 500/\text{mm}^3) that has persisted for 6 days despite appropriate initial empiric antibacterial therapy.
Recognizing the timeline and the unresponsiveness to piperacillin-tazobactam is critical for determining the next phase of the management algorithm.
2
Assess the risk of secondary or occult infections.
Patients with profound and prolonged neutropenia are at an exceptionally high risk for invasive fungal infections, most commonly caused by Candida and Aspergillus species.
Fungal pathogens are a common cause of culture-negative persistent fever in hematologic malignancy patients undergoing induction chemotherapy.
3
Apply the standard treatment protocol for persistent neutropenic fever.
Guidelines dictate that if a high-risk neutropenic patient remains febrile after 4 to 7 days of broad-spectrum antibacterial therapy and has no identified source, an empiric antifungal agent must be added.
Early initiation of antifungal therapy reduces mortality from occult invasive fungal infections in this vulnerable population.
4
Select the appropriate pharmacotherapy to add.
Adding intravenous caspofungin (an echinocandin) provides excellent empiric coverage for the suspected fungal organisms.
Echinocandins, liposomal amphotericin B, or mold-active azoles are the drugs of choice in this scenario.

Anahtar Kavram

In high-risk patients with neutropenic fever that persists for 4 to 7 days despite appropriate broad-spectrum antibacterial therapy, empiric antifungal coverage (e.g., caspofungin) should be added to prevent severe morbidity and mortality from invasive fungal infections.
Tahmini Süre:1m 30s
Soru 234Soru →

A 28-year-old male graduate student presents to the university health center reporting a 3-day history of profound fatigue, a severe sore throat, and a widespread rash. He notes that 14 days ago, he engaged in unprotected receptive anal intercourse with a new male partner whose infectious status is unknown. His temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}). Physical examination reveals tender cervical and axillary lymphadenopathy, pharyngeal erythema without exudate, and a diffuse maculopapular rash on the trunk and extremities. The physician suspects an acute viral illness and initiates the standard diagnostic algorithm for the most likely pathogen.

Arrange the following steps in the most appropriate chronological sequence for the diagnosis and initial management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) HIV-1/2 antigen/antibody combination immunoassay, 2) HIV-1/HIV-2 antibody differentiation immunoassay, 3) HIV-1 NAAT, 4) Obtain baseline genotypic resistance testing, and 5) Initiate empiric antiretroviral therapy.
The standard of care for suspected acute HIV follows a strict chronological pathway. Diagnosis begins with the 4th-generation Ag/Ab immunoassay. If positive, it is followed by an antibody differentiation assay. In acute infection, the differentiation assay is negative or indeterminate because antibodies have not yet formed, which mandates an HIV-1 NAAT to confirm the diagnosis. Once confirmed, blood for genotypic resistance testing must be drawn prior to starting treatment. Finally, empiric antiretroviral therapy is initiated rapidly without waiting for the resistance results to return.

Adım Adım Çözüm

1
Recognize the clinical presentation of acute HIV infection (acute retroviral syndrome).
The patient's timeline (14 days post-high-risk exposure) and symptoms (fever, pharyngitis, lymphadenopathy, maculopapular rash) are highly suspicious for acute HIV.
Identifying acute HIV dictates the need for a specific diagnostic algorithm, as traditional antibody-only tests will be falsely negative during this window period.
2
Sequence the CDC diagnostic testing algorithm for HIV.
The initial step is the 4th-generation Ag/Ab immunoassay, followed by the antibody differentiation assay, and concluding with the HIV-1 NAAT.
The 4th-generation test detects the p24 antigen early. The reflex differentiation assay will be negative/indeterminate because antibodies haven't formed yet. The NAAT resolves this by directly detecting viral RNA, confirming acute infection.
3
Determine the optimal sequence for initiating treatment.
Genotypic resistance testing is drawn first, followed immediately by the rapid initiation of empiric antiretroviral therapy (ART).
ART suppresses viral replication, so resistance testing must be drawn beforehand to ensure accurate baseline data. However, ART initiation should not be delayed while waiting days to weeks for these results.

Anahtar Kavram

The diagnosis of acute HIV requires a sequential algorithm: a 4th-generation Ag/Ab combination immunoassay, followed by an antibody differentiation assay (often negative in early infection), and finally an HIV-1 NAAT for confirmation. Management requires drawing genotypic resistance labs prior to the rapid initiation of empiric antiretroviral therapy.
Soru 235Soru →

An infectious diseases consultation is requested for a 74-year-old woman admitted with subacute bacterial endocarditis. She has a history of osteoarthritis and underwent a screening colonoscopy with polypectomy one month ago. She presented to the hospital with three weeks of low-grade fever, severe fatigue, and a new holosystolic murmur heard loudest at the cardiac apex. Transesophageal echocardiography revealed a 14 mm14\text{ mm}, highly mobile vegetation on the anterior mitral valve leaflet.

Four sets of blood cultures drawn upon admission are positive for *Enterococcus faecalis*. The microbiology laboratory provides the following antimicrobial susceptibility report:

AntimicrobialSusceptibility Result
AmpicillinSusceptible
CeftriaxoneResistant
Gentamicin (high-level screen)Resistant
LinezolidSusceptible
VancomycinSusceptible

Based on the susceptibility profile provided, which of the following is the most appropriate targeted pharmacotherapy to achieve bactericidal activity in this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous ampicillin and intravenous ceftriaxone

Cevap

Intravenous ampicillin and intravenous ceftriaxone
The correct targeted therapy is intravenous ampicillin and intravenous ceftriaxone. Enterococcal infective endocarditis requires a bactericidal regimen, which historically consisted of ampicillin plus an aminoglycoside (e.g., gentamicin) to achieve synergy. However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR), meaning gentamicin cannot penetrate the cell wall and will not provide synergy. The standard of care for HLAR Enterococcus faecalis endocarditis is dual beta-lactam therapy with ampicillin and ceftriaxone. Even though enterococci are intrinsically resistant to cephalosporins in vitro, ceftriaxone saturates penicillin-binding proteins (PBP) 2 and 3, allowing ampicillin to more effectively bind its targets (PBP 4 and 5). This mechanism results in profound synergistic bactericidal activity, effectively curing the endocarditis while avoiding aminoglycoside-induced nephrotoxicity.

Adım Adım Çözüm

1
Analyze the clinical presentation and primary diagnosis.
The patient has native valve infective endocarditis caused by Enterococcus faecalis.
Establishing the specific pathogen and site of infection dictates the necessity for a prolonged, bactericidal antimicrobial regimen.
2
Evaluate the microbiology susceptibility report.
The isolate is susceptible to ampicillin but shows high-level resistance to gentamicin (HLAR).
Enterococci are intrinsically tolerant to many antibiotics; bactericidal activity usually requires synergy between a cell-wall active agent (like ampicillin) and an aminoglycoside. HLAR eliminates the option of using gentamicin for synergy.
3
Determine the alternative synergistic regimen for HLAR Enterococcus faecalis.
Ampicillin combined with ceftriaxone is selected as the optimal regimen.
Despite enterococci being intrinsically resistant to cephalosporins (as shown on the report), ceftriaxone synergizes with ampicillin by saturating complementary penicillin-binding proteins (PBPs), achieving the necessary bactericidal effect without nephrotoxicity.

Anahtar Kavram

Management of Enterococcus faecalis infective endocarditis with High-Level Aminoglycoside Resistance (HLAR) using dual beta-lactam synergy (Ampicillin + Ceftriaxone).
Tahmini Süre:1m 30s
Soru 236Soru →

A 55-year-old man is evaluated in the hospital prior to discharge. Three days ago, he was admitted for a diabetic foot infection characterized by a 3-cm area of erythema, induration, and warmth surrounding a shallow, non-purulent ulcer on the plantar surface of his right foot. Upon admission, he was afebrile, and his vital signs were within normal limits. He was started on empiric intravenous vancomycin and piperacillin-tazobactam. Today, the erythema has decreased to 1 cm, and the patient is ambulating without difficulty. Deep tissue cultures obtained during initial debridement on admission have grown methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus agalactiae. Susceptibility testing shows both isolates are sensitive to cefazolin, cephalexin, and amoxicillin-clavulanate. The patient is tolerating a regular diet. Which of the following is the most appropriate antibiotic regimen for this patient upon discharge?

Cevabı ve açıklamayı göster

Cevap: Oral cephalexin

Cevap

Oral cephalexin
Oral cephalexin is the most appropriate next step because it provides targeted, narrow-spectrum coverage against the specific identified organisms (MSSA and Streptococcus agalactiae). The patient is clinically stable, recovering well, and tolerating a regular diet, which safely allows for the discontinuation of broad-spectrum intravenous therapy (vancomycin and piperacillin-tazobactam) in favor of a highly bioavailable, targeted oral agent.

Adım Adım Çözüm

1
Identify the patient's clinical status and trajectory.
The patient is clinically improving, hemodynamically stable, and tolerating oral intake.
This establishes that the patient is a safe candidate for transition from intravenous to oral antibiotic therapy.
2
Analyze the deep tissue culture and susceptibility data.
Cultures grew methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus agalactiae, both of which are sensitive to first-generation cephalosporins.
Definitive culture data from deep tissue is the gold standard for guiding targeted therapy in diabetic foot infections.
3
Apply principles of antibiotic stewardship.
Select oral cephalexin to complete the treatment course.
De-escalating from broad-spectrum empiric therapy to the narrowest-spectrum, effective oral agent minimizes adverse effects, reduces healthcare costs, and prevents the emergence of antimicrobial resistance.

Anahtar Kavram

De-escalation of empiric broad-spectrum antibiotics to targeted, narrow-spectrum oral therapy based on clinical improvement and definitive culture susceptibilities.
Soru 237Soru →

A 48-year-old woman is brought to the emergency department by her husband due to a 24-hour history of severe generalized headache, high fever, and progressive confusion. She has a history of a deceased-donor renal transplant 3 years ago and takes tacrolimus, mycophenolate mofetil, and prednisone. Her temperature is 39.2°C (102.6°F), blood pressure is 112/68 mmHg, pulse is 115/min, and respirations are 18/min. On examination, the patient is lethargic but arousable to verbal stimuli. Marked nuchal rigidity is present. Neurologic examination reveals a new-onset right-sided pronator drift and a mild right lower facial droop. Arrange the following next steps in management in the most appropriate chronological order.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Obtain peripheral blood cultures, 2) Administer empiric dexamethasone and antimicrobials, 3) Obtain a CT scan of the head, and 4) Perform a lumbar puncture.
In patients with suspected bacterial meningitis, the primary goal is to obtain cerebrospinal fluid (CSF) for analysis and initiate targeted antibiotics as rapidly as possible. However, performing a lumbar puncture (LP) in the setting of increased intracranial pressure due to a mass lesion can lead to fatal brain herniation. Therefore, a head CT must be performed prior to LP in patients who meet specific high-risk criteria, which include: an immunocompromised state (e.g., solid organ transplant), altered level of consciousness, focal neurologic deficits (e.g., hemiparesis, facial droop), new-onset seizures, or papilledema. Because obtaining a head CT will delay the LP, empiric therapy must not be postponed. The optimal sequence is to immediately draw blood cultures to maximize diagnostic yield, rapidly administer empiric antibiotics alongside dexamethasone (to reduce meningeal inflammation), perform the head CT to rule out mass effect, and finally perform the LP if the CT shows it is safe to proceed.

Adım Adım Çözüm

1
Identify the suspected diagnosis and recognize red flag features.
The patient has symptoms of bacterial meningitis (fever, headache, nuchal rigidity, confusion) along with focal neurologic deficits (pronator drift, facial droop) and an immunocompromised state.
Recognizing red flags dictates whether a lumbar puncture can be performed immediately or if prior neuroimaging is required.
2
Determine the safety of an immediate lumbar puncture.
Lumbar puncture must be delayed until a head CT is performed.
Patients with altered mental status, focal neurologic deficits, or immunocompromise are at high risk for intracranial mass effect. An immediate LP could precipitate fatal brain herniation.
3
Sequence the diagnostic and therapeutic interventions to avoid delaying treatment.
Blood cultures are drawn first, followed immediately by empiric antibiotics and dexamethasone, then the CT scan, and finally the LP.
Because the CT scan delays the definitive diagnostic LP, empiric antibiotics must not be withheld. Blood cultures take minutes and should be drawn prior to antibiotics to optimize microbiological yield.

Anahtar Kavram

Management sequence for suspected bacterial meningitis with indications for head CT before lumbar puncture.
Tahmini Süre:1m 30s
Soru 238Soru →

Match each patient's clinical scenario regarding malaria prevention or treatment with the most appropriate targeted pharmacotherapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 28-year-old primigravida at 16 weeks gestation is evaluated in the clinic prior to a 2-week trip to a chloroquine-resistant malaria-endemic region in sub-Saharan Africa. She is asymptomatic and her pregnancy is uncomplicated.
A 34-year-old man presents with cyclic fevers. Blood smear reveals Plasmodium vivax. His G6PD activity is normal. He is initiated on blood schizonticidal therapy with chloroquine.
A 42-year-old woman returning from West Africa is brought to the emergency department with high fever, confusion, and oliguria. Laboratory analysis reveals a Plasmodium falciparum parasitemia of 15%.
A 25-year-old man recently returned from Kenya presents to the clinic with a fever of 39.0°C (102.2°F). He is alert and oriented with normal renal and hepatic function. Blood smear reveals Plasmodium falciparum with 1% parasitemia.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches require pairing the pregnant traveler with Mefloquine, the P. vivax patient with Primaquine, the severe P. falciparum patient with Intravenous artesunate, and the uncomplicated P. falciparum patient with Artemether-lumefantrine.
Malaria management is highly specific to the clinical context. Mefloquine is the safe and recommended chemoprophylaxis for pregnant women traveling to chloroquine-resistant areas. Primaquine specifically targets the dormant liver hypnozoites of Plasmodium vivax to prevent relapse. Severe Plasmodium falciparum malaria (indicated by high parasitemia, confusion, and organ failure) requires emergent intravenous artesunate. Uncomplicated Plasmodium falciparum can be safely managed with oral artemisinin-based combination therapies, such as artemether-lumefantrine.

Adım Adım Çözüm

1
Evaluate the clinical status and species of malaria for each patient.
Patients are categorized into: prophylaxis in pregnancy, P. vivax hypnozoite eradication, severe P. falciparum, and uncomplicated P. falciparum.
Malaria treatment and prophylaxis algorithms depend heavily on clinical severity, Plasmodium species, local resistance patterns, and patient-specific factors.
2
Determine the appropriate regimen for the pregnant traveler.
Mefloquine is selected.
Mefloquine is the only recommended chemoprophylaxis for chloroquine-resistant areas that is safe in all trimesters of pregnancy. Doxycycline is teratogenic, and atovaquone-proguanil lacks sufficient safety data.
3
Determine the appropriate regimen to eradicate P. vivax hypnozoites.
Primaquine is selected.
P. vivax and P. ovale have dormant liver stages (hypnozoites) that standard blood schizonticides do not kill. Primaquine (or tafenoquine) is required to prevent relapse, provided the patient has normal G6PD levels.
4
Determine the appropriate therapy for severe P. falciparum malaria.
Intravenous artesunate is selected.
Severe malaria (defined by parasitemia >5%, altered mental status, renal failure, or respiratory distress) requires emergent parenteral therapy with intravenous artesunate to rapidly clear the parasite burden.
5
Determine the appropriate therapy for uncomplicated P. falciparum malaria.
Artemether-lumefantrine is selected.
Uncomplicated falciparum malaria in a chloroquine-resistant region is best treated with an oral artemisinin-based combination therapy (ACT).

Anahtar Kavram

Pharmacotherapy for malaria depends on the severity of illness, Plasmodium species, local resistance patterns, and patient-specific contraindications such as pregnancy or G6PD deficiency.
Soru 239Soru →

A 68-year-old woman is brought to the emergency department by her family due to a severe headache, fever, and confusion that started earlier today. On examination, her temperature is 39.2°C (102.6°F), blood pressure is 110/70 mm Hg, and heart rate is 115/min. She exhibits nuchal rigidity and a new-onset right-sided facial droop with right arm weakness. Arrange the following steps in the most appropriate chronological sequence for the immediate management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of steps is: 1) Obtain blood cultures, 2) Administer empiric intravenous antibiotics and dexamethasone, 3) Perform a non-contrast CT scan of the head, and 4) Perform a lumbar puncture.
The patient presents with classic signs of meningitis along with focal neurologic deficits (right-sided weakness) and altered mental status. These 'red flags' require a head CT prior to a lumbar puncture to rule out a mass lesion or significant cerebral edema that could lead to herniation during the procedure. However, treating bacterial meningitis is a race against time. Therefore, blood cultures must be drawn immediately, followed by the immediate administration of empiric antibiotics and dexamethasone. Once therapy is initiated, the patient can safely undergo a CT scan of the head. If the CT is clear of mass effect, a lumbar puncture should then be performed. Although antibiotics may sterilize the cerebrospinal fluid culture, other parameters (cell count, glucose, protein, PCR) will still provide critical diagnostic information.

Adım Adım Çözüm

1
Recognize the clinical presentation of suspected bacterial meningitis with high-risk features.
The patient has symptoms of meningitis (fever, headache, nuchal rigidity) along with red flags for increased intracranial pressure: age over 60, altered mental status, and focal neurologic deficits (facial droop, arm weakness).
Identifying high-risk features is crucial as it alters the standard management pathway by necessitating neuroimaging prior to a lumbar puncture.
2
Determine the first step in management.
Obtain blood cultures.
Blood cultures should be obtained before administering antibiotics to optimize the chances of identifying the causative pathogen, provided it does not cause a substantial delay in treatment.
3
Determine the timing of empiric medical therapy.
Administer empiric intravenous antibiotics and dexamethasone.
Bacterial meningitis is a medical emergency. Antibiotics and dexamethasone must be given immediately after blood cultures are drawn and should never be delayed for a CT scan or lumbar puncture.
4
Decide on the sequence of diagnostic procedures (CT vs. LP).
Perform a non-contrast CT scan of the head, followed by a lumbar puncture.
Because the patient has high-risk features for increased intracranial pressure, a CT scan must be performed first to rule out a mass lesion. Performing an LP without prior imaging in this setting could precipitate fatal brain herniation.

Anahtar Kavram

In patients with suspected bacterial meningitis who have indications for a head CT (e.g., focal neurologic deficit, altered mental status, immunocompromised state, age over 60), blood cultures should be drawn and empiric antibiotics administered immediately, prior to obtaining the CT scan and performing a lumbar puncture.
Tahmini Süre:1m 0s
Soru 240Soru →

During multidisciplinary rounds in the surgical intensive care unit, the team evaluates the antimicrobial regimen for a 54-year-old man. The patient underwent an exploratory laparotomy 8 days ago for a perforated viscus. On his fifth postoperative day, he developed a temperature of 38.9°C (102.0°F) and tachycardia. His right internal jugular central venous catheter, which had been placed preoperatively, was removed, and blood cultures were drawn from peripheral veins and the catheter before removal. Empiric therapy with intravenous vancomycin and cefepime was initiated. Today, the microbiology laboratory reports that two out of two blood culture sets are growing Staphylococcus aureus. The susceptibility panel indicates resistance to penicillin and ampicillin, but susceptibility to oxacillin, cefazolin, vancomycin, and daptomycin. The patient has no known drug allergies. His current temperature is 37.2°C (99.0°F), blood pressure is 128/82 mmHg, and pulse is 82/min. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and cefepime; start intravenous cefazolin

Cevap

Discontinue the empiric broad-spectrum antibiotics and transition to intravenous cefazolin for targeted MSSA therapy.
The patient has Methicillin-Susceptible Staphylococcus aureus (MSSA) bacteremia, indicated by susceptibility to oxacillin. The cornerstone of antimicrobial stewardship is de-escalating empiric therapy to the narrowest spectrum, most effective agent once culture and susceptibility data are available. For MSSA bacteremia, intravenous anti-staphylococcal beta-lactams (such as cefazolin, nafcillin, or oxacillin) are the drugs of choice. Extensive clinical data demonstrate that beta-lactams are superior to vancomycin for clearing MSSA bacteremia, resulting in lower rates of clinical failure, relapse, and mortality. Therefore, discontinuing the empiric vancomycin and cefepime and initiating intravenous cefazolin is the most appropriate next step.

Adım Adım Çözüm

1
Interpret the blood culture and susceptibility results.
The pathogen is oxacillin-susceptible Staphylococcus aureus (MSSA).
Oxacillin susceptibility defines the isolate as MSSA, which changes the preferred treatment algorithm.
2
Evaluate the current empiric antimicrobial regimen (vancomycin and cefepime).
The current regimen is too broad and vancomycin is suboptimal for MSSA.
Antimicrobial stewardship dictates de-escalating to the narrowest effective agent. Beta-lactams are superior to vancomycin for MSSA.
3
Select the optimal targeted therapy.
Intravenous cefazolin (or nafcillin/oxacillin) is selected.
Cefazolin provides potent, narrow-spectrum bactericidal activity against MSSA with an excellent safety profile, making it the standard of care.

Anahtar Kavram

In patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) bacteremia, targeted therapy with an intravenous anti-staphylococcal beta-lactam (e.g., cefazolin, nafcillin) is superior to vancomycin, leading to improved clinical outcomes and reduced mortality.
Tahmini Süre:1m 0s
ÖncekiSayfa 12 / 26Sonraki
Infectious Diseases Alıştırma Soruları — USMLE Step 2 CK — Sayfa 12 | Examkin